FDA Inspection
North Florida Reproductive Biology LaboratoryNorth Florida Reproductive Biology Laboratory – FDA Inspection, Jul 13, 2017
Record Details
This FDA Inspection record concerns North Florida Reproductive Biology Laboratory, with an inspection on July 13, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- July 13, 2017
- Product Type
- Biologics
- Person
- Valerie J. Grecek-Trinh (Issuing Officer)
View Company Profile
ID · caf1c2b3-aaf3-41a2-bf45-2d03ea81d6fe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1017722
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
Other FDA inspections of North Florida Reproductive Biology Laboratory
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 12, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 28, 2019 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 12, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 13, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for North Florida Reproductive Biology Laboratory
- FDA Inspection 1236567 - 2024-04-12
- FDA Inspection 1095130 - 2019-06-28
- FDA Inspection 917629 - 2015-03-12
- FDA Inspection 798595 - 2012-09-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.